- Vasculoprotective Effects of Vildagliptin. Focus on Atherogenesis - (https://pubmed.ncbi.nlm.nih.gov/32218354/ )
- Efficacy and short-term side effects of sitagliptin, vildagliptin and saxagliptin in Chinese diabetes: a randomized clinical trial - (https://pubmed.ncbi.nlm.nih.gov/30822272/ )
- Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131578/ )
- Hormonal and metabolic effects of morning or evening dosing of the dipeptidyl peptidase IV inhibitor vildagliptin in patients with type 2 diabetes - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909805/ )
- Management of type 2 diabetes in treatment-naive elderly patients: benefits and risks of vildagliptin monotherapy - (https://pubmed.ncbi.nlm.nih.gov/17878242/ )
Galvus Met (50 mg/850 mg) - Novartis India Ltd.
Galvus Met (50 mg/850 mg) Tablet
Generic : Vildagliptin
When is Galvus Met (50 mg/850 mg) prescribed?
It is prescribed for -